Endologix Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif., Jan. 6, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the 32nd Annual JP Morgan Healthcare Conference in San Francisco, CA.

Help employers find you! Check out all the jobs and post your resume.

Back to news